What Are Traditional GLP-1 Agonists
Across GLP-1 medications, the same three injection sites are recommended: your abdomen, the front or outer part of your thigh, and the back of your upper arm
What Happened, in Order On April 22, 2026, FDA removed GHK-Cu (except for injectable routes of administration) from Category 1 of the 503A bulks reference list
Important safety warnings include: Acute pancreatitis : Seek urgent medical care if you experience sudden, severe and persistent abdominal pain (which may radiate to your back), with or without vomiting Diabetic retinopathy complications : Patients with pre-existing retinopathy should be monitored closely, especially during rapid improvement in blood glucose control Dehydration risk : The gastrointestinal side effects may cause dehydration, potentially leading to acute kidney injury
Methods: We described a case series of patients experiencing AP while on GLP-1 RAs
This means that while supplements are helpful for maintaining overall wellness, they may not provide the rapid and visible results that patients seek from IV or injection-based treatments